Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BioNTech SEBNTX · Entity 3181 | Chief Executive Officer · 10% owner | October 08, 2026 | October 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BioNTech SE
Report date October 08, 2026 · Filed October 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2026-10-09 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-10-08 · Sale · Disposed 27,000 · Balance 36,209 Row 2 · 2026-10-09 · Sale · Disposed 36,209 · Balance 0 |
| Ordinary SharesSEC Table I · non-derivative | IndirectSee Footnote | 39,218,111 |
Reported balance
Holding disclosure · report date 2026-10-08 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 39,218,111 F1: The ordinary shares are held by Medine GmbH. The reporting person is the sole shareholder of Medine GmbH. 106,721 of the ordinary shares noted herein are held for the benefit of an individual under a trust arrangement, pursuant to which Medine GmbH exercises voting power, but not dispositive power, over such ordinary shares for so long as such ordinary shares are held in trust. The reporting person may be deemed to beneficially own the ordinary shares held by Medine GmbH. |
Filing footnotes · ownership attribution and instrument terms
F1: The ordinary shares are held by Medine GmbH. The reporting person is the sole shareholder of Medine GmbH. 106,721 of the ordinary shares noted herein are held for the benefit of an individual under a trust arrangement, pursuant to which Medine GmbH exercises voting power, but not dispositive power, over such ordinary shares for so long as such ordinary shares are held in trust. The reporting person may be deemed to beneficially own the ordinary shares held by Medine GmbH.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 09, 2026 Filed Oct 9, 2026 20:47 UTC | BioNTech SE BNTX · Entity 3181 | SaleOrdinary Shares | 36,209 | $95.37 | $3,453,371.82 |
DisclosureSEC source: 0002123975-26-000035 · wk-form4_1791578831.xml · nonDerivative · entry 2 Sahin Ugur · CIK 0002123975 · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Read SEC document |
| October 08, 2026 Filed Oct 9, 2026 20:47 UTC | BioNTech SE BNTX · Entity 3181 | SaleOrdinary Shares | 27,000 | $92.31 | $2,492,483.40 |
DisclosureSEC source: 0002123975-26-000035 · wk-form4_1791578831.xml · nonDerivative · entry 1 Sahin Ugur · CIK 0002123975 · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,209 Read SEC document |
| October 07, 2026 Filed Oct 7, 2026 21:14 UTC | BioNTech SE BNTX · Entity 3181 | SaleOrdinary Shares | 24,000 | $95.86 | $2,300,632.80 |
DisclosureSEC source: 0002123975-26-000033 · wk-form4_1791407643.xml · nonDerivative · entry 1 Sahin Ugur · CIK 0002123975 · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 63,209 Read SEC document |
| October 06, 2026 Filed Oct 6, 2026 20:59 UTC | BioNTech SE BNTX · Entity 3181 | SaleOrdinary Shares | 21,000 | $96.81 | $2,032,995.30 |
DisclosureSEC source: 0002123975-26-000031 · wk-form4_1791320345.xml · nonDerivative · entry 2 Sahin Ugur · CIK 0002123975 · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 87,209 Read SEC document |
| October 05, 2026 Filed Oct 6, 2026 20:59 UTC | BioNTech SE BNTX · Entity 3181 | SaleOrdinary Shares | 72,000 | $97.23 | $7,000,646.40 |
DisclosureSEC source: 0002123975-26-000031 · wk-form4_1791320345.xml · nonDerivative · entry 1 Sahin Ugur · CIK 0002123975 · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,209 Read SEC document |
| October 02, 2026 Filed Oct 3, 2026 00:27 UTC | BioNTech SE BNTX · Entity 3181 | SaleOrdinary Shares | 17,000 | $96.72 | $1,644,323.30 |
DisclosureSEC source: 0002123975-26-000029 · wk-form4_1790972861.xml · nonDerivative · entry 2 Sahin Ugur · CIK 0002123975 · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 180,209 Read SEC document |
| October 01, 2026 Filed Oct 3, 2026 00:27 UTC | BioNTech SE BNTX · Entity 3181 | SaleOrdinary Shares | 17,000 | $97.46 | $1,656,745.20 |
DisclosureSEC source: 0002123975-26-000029 · wk-form4_1790972861.xml · nonDerivative · entry 1 Sahin Ugur · CIK 0002123975 · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 197,209 Read SEC document |
| September 30, 2026 Filed Oct 1, 2026 00:29 UTC | BioNTech SE BNTX · Entity 3181 | SaleOrdinary Shares | 32,000 | $98.12 | $3,139,849.60 |
DisclosureSEC source: 0002123975-26-000027 · wk-form4_1790800195.xml · nonDerivative · entry 2 Sahin Ugur · CIK 0002123975 · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 214,209 Read SEC document |
| September 29, 2026 Filed Oct 1, 2026 00:29 UTC | BioNTech SE BNTX · Entity 3181 | SaleOrdinary Shares | 34,000 | $98.26 | $3,340,809.40 |
DisclosureSEC source: 0002123975-26-000027 · wk-form4_1790800195.xml · nonDerivative · entry 1 Sahin Ugur · CIK 0002123975 · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 246,209 Read SEC document |
| September 28, 2026 Filed Sep 28, 2026 21:16 UTC | BioNTech SE BNTX · Entity 3181 | SaleOrdinary Shares | 34,000 | $98.47 | $3,347,918.80 |
DisclosureSEC source: 0002123975-26-000025 · wk-form4_1790630190.xml · nonDerivative · entry 2 Sahin Ugur · CIK 0002123975 · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 280,209 Read SEC document |
| September 25, 2026 Filed Sep 28, 2026 21:16 UTC | BioNTech SE BNTX · Entity 3181 | SaleOrdinary Shares | 27,000 | $98.69 | $2,664,581.40 |
DisclosureSEC source: 0002123975-26-000025 · wk-form4_1790630190.xml · nonDerivative · entry 1 Sahin Ugur · CIK 0002123975 · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 314,209 Read SEC document |
| September 24, 2026 Filed Sep 24, 2026 20:26 UTC | BioNTech SE BNTX · Entity 3181 | SaleOrdinary Shares | 39,000 | $98.99 | $3,860,660.70 |
DisclosureSEC source: 0002123975-26-000023 · wk-form4_1790281568.xml · nonDerivative · entry 2 Sahin Ugur · CIK 0002123975 · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 341,209 Read SEC document |
| September 23, 2026 Filed Sep 24, 2026 20:26 UTC | BioNTech SE BNTX · Entity 3181 | SaleOrdinary Shares | 30,000 | $99.40 | $2,982,081.00 |
DisclosureSEC source: 0002123975-26-000023 · wk-form4_1790281568.xml · nonDerivative · entry 1 Sahin Ugur · CIK 0002123975 · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 380,209 Read SEC document |
| September 22, 2026 Filed Sep 22, 2026 21:04 UTC | BioNTech SE BNTX · Entity 3181 | SaleOrdinary Shares | 46,000 | $100.72 | $4,633,037.20 |
DisclosureSEC source: 0002123975-26-000021 · wk-form4_1790111057.xml · nonDerivative · entry 2 Sahin Ugur · CIK 0002123975 · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 410,209 Read SEC document |
| September 21, 2026 Filed Sep 22, 2026 21:04 UTC | BioNTech SE BNTX · Entity 3181 | SaleOrdinary Shares | 33,000 | $97.81 | $3,227,720.10 |
DisclosureSEC source: 0002123975-26-000021 · wk-form4_1790111057.xml · nonDerivative · entry 1 Sahin Ugur · CIK 0002123975 · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 456,209 Read SEC document |
| September 18, 2026 Filed Sep 18, 2026 20:41 UTC | BioNTech SE BNTX · Entity 3181 | SaleOrdinary Shares | 30,000 | $96.22 | $2,886,729.00 |
DisclosureSEC source: 0002123975-26-000019 · wk-form4_1789764092.xml · nonDerivative · entry 2 Sahin Ugur · CIK 0002123975 · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 489,209 Read SEC document |
| September 17, 2026 Filed Sep 18, 2026 20:41 UTC | BioNTech SE BNTX · Entity 3181 | SaleOrdinary Shares | 34,000 | $98.60 | $3,352,342.20 |
DisclosureSEC source: 0002123975-26-000019 · wk-form4_1789764092.xml · nonDerivative · entry 1 Sahin Ugur · CIK 0002123975 · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 519,209 Read SEC document |
| September 16, 2026 Filed Sep 16, 2026 20:46 UTC | BioNTech SE BNTX · Entity 3181 | SaleOrdinary Shares | 15,000 | $96.09 | $1,441,339.50 |
DisclosureSEC source: 0002123975-26-000017 · wk-form4_1789591576.xml · nonDerivative · entry 2 Sahin Ugur · CIK 0002123975 · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 553,209 Read SEC document |
| September 15, 2026 Filed Sep 16, 2026 20:46 UTC | BioNTech SE BNTX · Entity 3181 | SaleOrdinary Shares | 34,000 | $96.49 | $3,280,636.20 |
DisclosureSEC source: 0002123975-26-000017 · wk-form4_1789591576.xml · nonDerivative · entry 1 Sahin Ugur · CIK 0002123975 · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 568,209 Read SEC document |
| September 14, 2026 Filed Sep 14, 2026 20:50 UTC | BioNTech SE BNTX · Entity 3181 | SaleOrdinary Shares | 41,000 | $99.45 | $4,077,314.70 |
DisclosureSEC source: 0002123975-26-000015 · wk-form4_1789419036.xml · nonDerivative · entry 2 Sahin Ugur · CIK 0002123975 · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 602,209 Read SEC document |
| September 11, 2026 Filed Sep 14, 2026 20:50 UTC | BioNTech SE BNTX · Entity 3181 | SaleOrdinary Shares | 45,000 | $96.93 | $4,362,021.00 |
DisclosureSEC source: 0002123975-26-000015 · wk-form4_1789419036.xml · nonDerivative · entry 1 Sahin Ugur · CIK 0002123975 · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 643,209 Read SEC document |
| September 10, 2026 Filed Sep 11, 2026 21:18 UTC | BioNTech SE BNTX · Entity 3181 | SaleOrdinary Shares | 20,500 | $96.31 | $1,974,287.35 |
DisclosureSEC source: 0002123975-26-000013 · wk-form4_1789161500.xml · nonDerivative · entry 1 Sahin Ugur · CIK 0002123975 · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 688,209 Read SEC document |
| September 09, 2026 Filed Sep 9, 2026 21:29 UTC | BioNTech SE BNTX · Entity 3181 | SaleOrdinary Shares | 36,000 | $97.78 | $3,520,144.80 |
DisclosureSEC source: 0002123975-26-000011 · wk-form4_1788989388.xml · nonDerivative · entry 2 Sahin Ugur · CIK 0002123975 · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 708,709 Read SEC document |
| September 08, 2026 Filed Sep 9, 2026 21:29 UTC | BioNTech SE BNTX · Entity 3181 | SaleOrdinary Shares | 37,000 | $99.20 | $3,670,518.40 |
DisclosureSEC source: 0002123975-26-000011 · wk-form4_1788989388.xml · nonDerivative · entry 1 Sahin Ugur · CIK 0002123975 · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 744,709 Read SEC document |
| September 04, 2026 Filed Sep 8, 2026 20:10 UTC | BioNTech SE BNTX · Entity 3181 | SaleOrdinary Shares | 31,500 | $103.52 | $3,260,823.30 |
DisclosureSEC source: 0002123975-26-000008 · wk-form4_1788898236.xml · nonDerivative · entry 2 Sahin Ugur · CIK 0002123975 · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 781,709 Read SEC document |
| September 03, 2026 Filed Sep 8, 2026 20:10 UTC | BioNTech SE BNTX · Entity 3181 | SaleOrdinary Shares | 45,000 | $102.85 | $4,628,232.00 |
DisclosureSEC source: 0002123975-26-000008 · wk-form4_1788898236.xml · nonDerivative · entry 1 Sahin Ugur · CIK 0002123975 · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 813,209 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.